It is specified, that the drug is intended for general non-inhalation anesthesia, that is, a drug for narcosis.
“Ketamine-ENDOPHARM” is used in dogs and cats for pain relief and general non-inhalation anesthesia together with butorphanol and medetomidine, or combined with xylazine,” explained the representatives of the company.
They also added that the new veterinary drug can be used as monotherapy in cats for immobilization, or during minor surgeries that don’t require muscle relaxation.
Experts noted that the new drug is only being used at in-patient veterinary clinics, and won’t be available for purchase through veterinary pharmacies.
“In Russia Ketamine is a controlled substance classified as a Schedule II narcotic drug under the List of narcotic drugs, psychotropic substances and their precursors,” the company explained.
The new veterinary drug is available as a 100 mg/ml solution for injection in 5 ml vials.
«The Moscow manufacturers keep their successful development of products for animals and animal health. Thus, the Moscow Endocrine Plant received a registration certificate for veterinary anesthetic for general non-inhalation anesthesia in cats and dogs. Currently, requests for the purchase of this drug are being collected from regional in-patient veterinary clinics,” Vladislav Ovchinsky, Head of the Moscow Department of Investment and Industrial Policy, was quoted as saying in a statement posted on the website of the Mayor of Moscow.
